| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 18.9 | 15.6 | 14.1 |
| Other income | 0.0 | 0.0 | 1.4 |
| Total income | 18.9 | 15.7 | 15.5 |
| Profit before exceptional items & tax | 1.0 | 0.8 | -11.2 |
| Profit before tax | 1.0 | 0.8 | -11.2 |
| Net profit | 0.7 | 0.9 | -10.5 |
| Operating margin | 5.3% | 5.1% | -72.3% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, quarter on quarter | -22.20% |
|---|---|
| Revenue, year on year | +34.00% |
| Operating profit, year on year | +107.90% |
| Operating profit, quarter on quarter | +25.00% |
BSE results filing, NSE: VINEETLAB. Figures extracted from the filing.
Vineet Laboratories Ltd: key numbers
- Share price
- ₹36.98
- Market cap
- ₹71.02 Cr
- Revenue (annual)
- ₹59.40 Cr
- Net profit (annual)
- ₹1.11 Cr
- P/E (TTM)
- 64.0×Sector 47.4×
- Promoter holding
- 5.98%+0.00% QoQ
- FII holding
- 0.50%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vineet Laboratories Ltd
All →Vineet Laboratories Other Announcement
Vineet Laboratories received an extension from the Registrar of Companies, Hyderabad, to hold its 10th Annual General Meeting by 30th November 2026.
Vineet Laboratories Board Meeting Date
Vineet Laboratories Limited scheduled a board meeting for August 25, 2026, to approve the audited financial results for the quarter and year ended March 31, 2026.
Vineet Laboratories Other Announcement
Vineet Laboratories filed its Monitoring Agency Report for the quarter ended June 30, 2026, confirming the utilization of Rights Issue proceeds as per the offer document.
- Value
- ₹29.97 Cr
Vineet Laboratories Other Announcement
Vineet Laboratories Limited submitted a certificate declaring non-applicability of Corporate Governance provisions for the quarter ended June 30, 2026, due to meeting regulatory threshold exemptions.
Vineet Laboratories Management Change
Vineet Laboratories Limited has appointed Mr. Rajesh Kumar Kathulla as an Additional Director (Executive Category), effective June 11, 2026, subject to shareholder approval.
Vineet Laboratories Board Meeting Date
Vineet Laboratories scheduled a board meeting on July 15, 2026. The board will consider audited standalone financial results for FY26.